You are here
Guidance on the regulation of menstrual cups in Australia
Version 1.0, November 2018
Menstrual cups are therapeutic products which are exempt from inclusion on the Australian Register of Therapeutic Goods (ARTG).
Prior to 1 July 2018, menstrual cups were required to be listed on the ARTG. As a result of recent regulatory amendments, these products became exempt goods and therefore you are no longer required to have an ARTG entry for these products.
Menstrual cups are required to comply with Therapeutic Goods Order No.99 - Standards for Menstrual Cups 2018 before they can be supplied in Australia.
If you have a problem with a menstrual cup, please tell us about it at: Report a medical device adverse event (medical device user).
For sponsors and applicants
To reflect this regulatory amendment, you may need to do the following:
Existing ARTG entries
Sponsors with existing ARTG entries for tampons and/or menstrual cups can contact the TGA and request cancellation of their listed ARTG entries for these products. The TGA will notify you when your ARTG entry is cancelled.
If you decide to maintain ARTG listing for these products, you will continue be responsible for paying all respective future annual charges.
You no longer require ARTG listing for menstrual cups, and therefore you may decide to withdraw your application. If you choose to do so, you will be free from paying any future fees or charges. You should know, however, that there is no provision for us to refund the fees you have already paid.
If you decide to continue with your application, the TGA will follow the normal assessment process, and you will be obliged to pay all respective fees and charges (as applicable).
Related guidance and legislation
Menstrual cups must adhere to the requirements as set out in the:
- Therapeutic Goods Act (1989)
- Therapeutic Goods Regulations 1990
- Therapeutic Goods Advertising Code 2015
- Therapeutic Goods (Single Therapeutic Goods) Order No.1 of 1991
- Therapeutic Goods Order No.99 - Standards for Menstrual Cups
Each section below gives a brief outline of the regulatory requirements stated in Therapeutic Goods Order No.99 - Standards for Menstrual Cups.
Permissible raw materials
Menstrual cups should be manufactured from material suitable for their intended purpose. None of the ingredients contained in the menstrual cup should appear in a sufficient concentration to cause an irritant or toxic reaction when the product is used as directed. The manufacturer/supplier should hold sufficient evidence to demonstrate that materials used for this purpose are in compliance with pharmacopoeia or other relevant standards.
Your menstrual cup should be smooth and designed to minimise trauma to the end consumer.
Packaging materials and processes such as assembly and sealing should be validated under the requirements of relevant standards.
Menstrual cups must include the following labelling on the packaging of the product:
- The name of your product.
- The name and address of the manufacturer or the sponsor.
- The batch number or serial number for the product contained within the pack.
- If the package contains two or more menstrual cups, the name of all the goods within the package and the quantity of each of the goods.
- If your product comes in multiple sizes, the size of the unit contained in the pack.
- The following warning in letters having a height of not less than 1 mm.
IMPORTANT: Menstrual cups have been associated with Toxic Shock Syndrome (TSS). TSS is a rare but serious disease that may cause death. Read and keep the enclosed information.
The manufacturer or supplier of the menstrual cup must be able to be identified through their name or trademark, which should be permanently and legibly included on the packaging or on the Information Leaflet enclosed inside the pack.
An information leaflet containing the following information must be included with your product:
- Detailed instructions for use, including warnings emphasising the need for hygiene and care during insertion, as well as how the product should be cleaned prior to, and in between, uses.
- Information about Toxic Shock Syndrome (TSS), noting that while TSS is rarely associated with the use of menstrual cups, still occurs.
- Notification that your menstrual cup is not supplied sterile. Although AS 2869:2008 Tampons - Menstrual is written for tampons, it contains an example of wording that can be used in the information leaflet for the menstrual cup. Generally the leaflet should be written in plain English and a simple style that will be easy for younger women, and women for whom English is a second language, to understand. Other factors you might like to consider in the preparation of your information leaflet are:
Factor to consider Description Content
- Avoid using medical terms, or explain them if you must use them.
- The information must appear in English.
- You may elect to include the information in another language, but the translation of the information is your responsibility and will not be assessed or reviewed by us.
- Use a font style that is easy to read, avoiding fonts that look like handwriting.
- Use lower case as much as possible, keeping upper case for headings and warnings only.
- Choose the colour of your fonts and graphics carefully, and aim to maximise readability.
- As some people using your product may have limited language and literacy skills, support your information with graphics where possible.
- Graphic representations should be simply line drawings or photos.
- Limit graphic representations to the most important information.
- Make sure graphics appear next to the text that describes what they are representing.
An example of the information you might include is contained in Appendix E of AS 2869:2008 Tampons - Menstrual.
Post market - Ongoing responsibilities
Your menstrual cup must continue to meet all regulatory, safety and performance requirements and standards while it continues to be supplied within Australia.
Reporting adverse events associated with your product is a mandatory requirement.
Adverse events relating to your product can be reported at: Report a medical device adverse event (sponsor/manufacturer).
|Version||Description of change||Author||Effective date|
|V1.0||Original publication||Medical Devices Branch, Therapeutic Goods Administration||November 2018|